These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 31046175)

  • 21. Patterns of dementia treatment in older adults with Parkinson's disease using nationwide medical claims data.
    Yoon B; Kim HJ
    BMC Geriatr; 2022 Apr; 22(1):353. PubMed ID: 35459128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials.
    Kavirajan H; Schneider LS
    Lancet Neurol; 2007 Sep; 6(9):782-92. PubMed ID: 17689146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What is the impact of regulatory guidance and expiry of drug patents on dementia drug prescriptions in England? A trend analysis in the Clinical Practice Research Datalink.
    Walker VM; Davies NM; Kehoe PG; Martin RM
    Alzheimers Res Ther; 2018 May; 10(1):51. PubMed ID: 29843807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cumulative Anticholinergic Burden and its Predictors among Older Adults with Alzheimer's Disease Initiating Cholinesterase Inhibitors.
    Talwar A; Chatterjee S; Sherer J; Abughosh S; Johnson M; Aparasu RR
    Drugs Aging; 2024 Apr; 41(4):339-355. PubMed ID: 38467994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of anticholinergic burden on treatment modification, delirium and mortality in newly diagnosed dementia patients starting a cholinesterase inhibitor: A population-based study.
    Ah YM; Suh Y; Jun K; Hwang S; Lee JY
    Basic Clin Pharmacol Toxicol; 2019 Jun; 124(6):741-748. PubMed ID: 30511428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline.
    Raina P; Santaguida P; Ismaila A; Patterson C; Cowan D; Levine M; Booker L; Oremus M
    Ann Intern Med; 2008 Mar; 148(5):379-97. PubMed ID: 18316756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticholinergic component of the Drug Burden Index and the Anticholinergic Drug Scale as measures of anticholinergic exposure in older people in New Zealand: a population-level study.
    Narayan SW; Hilmer SN; Horsburgh S; Nishtala PS
    Drugs Aging; 2013 Nov; 30(11):927-34. PubMed ID: 23975730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Use of antipsychotics in patients with dementia in Spain: Comparison with prescription of acetylcholinesterase inhibitors and memantine and analysis of associations].
    Rodríguez Espinosa N; Gonzalez-Colaço Harmand M; Moro Miguel MA
    Rev Esp Geriatr Gerontol; 2024; 59(2):101446. PubMed ID: 38029634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of pneumonia in new users of cholinesterase inhibitors for dementia.
    Lai EC; Wong MB; Iwata I; Zhang Y; Hsieh CY; Kao Yang YH; Setoguchi S
    J Am Geriatr Soc; 2015 May; 63(5):869-76. PubMed ID: 25912671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stability of anticholinergic load in Australian community-dwelling older people: a longitudinal analysis.
    Mate KE; Barnett M; Kerr KP; Pond CD; Magin PJ
    Fam Pract; 2020 Jul; 37(3):314-320. PubMed ID: 31784733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer's Disease: A Network Meta-Analysis.
    Thancharoen O; Limwattananon C; Waleekhachonloet O; Rattanachotphanit T; Limwattananon P; Limpawattana P
    Drugs Aging; 2019 May; 36(5):435-452. PubMed ID: 30937879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potentially inappropriate prescriptions of anticholinergics drugs in Alzheimer's disease patients.
    Valladales-Restrepo LF; Duran-Lengua M; Machado-Alba JE
    Geriatr Gerontol Int; 2019 Sep; 19(9):913-917. PubMed ID: 31342625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of Anticholinergic Medication Use in Patients Prescribed Medications for the Treatment of Dementia.
    Ellard B; Galdo JA
    Consult Pharm; 2017 Dec; 32(12):764-769. PubMed ID: 29467069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antipsychotic use and myocardial infarction in older patients with treated dementia.
    Pariente A; Fourrier-Réglat A; Ducruet T; Farrington P; Béland SG; Dartigues JF; Moore N; Moride Y
    Arch Intern Med; 2012 Apr; 172(8):648-53; discussion 654-5. PubMed ID: 22450214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticholinergics Influence Transition from Normal Cognition to Mild Cognitive Impairment in Older Adults in Primary Care.
    Campbell NL; Lane KA; Gao S; Boustani MA; Unverzagt F
    Pharmacotherapy; 2018 May; 38(5):511-519. PubMed ID: 29600808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. One-Year Persistence with Donepezil, Memantine, and Rivastigmine in More than 66,000 Elderly Patients Followed in Poland.
    Kostev K; Kurylo P; Kosik J; Jacob L
    J Alzheimers Dis; 2019; 70(3):899-905. PubMed ID: 31306136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
    Daiello LA
    Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deprescribing cholinesterase inhibitors and memantine in dementia: guideline summary.
    Reeve E; Farrell B; Thompson W; Herrmann N; Sketris I; Magin PJ; Chenoweth L; Gorman M; Quirke L; Bethune G; Hilmer SN
    Med J Aust; 2019 Mar; 210(4):174-179. PubMed ID: 30771226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concurrent use of anticholinergic drugs and cholinesterase inhibitors: register-based study of over 700,000 elderly patients.
    Johnell K; Fastbom J
    Drugs Aging; 2008; 25(10):871-7. PubMed ID: 18808211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacist-initiated management of antagonistic interactions between anticholinergic drugs and acetyl cholinesterase inhibitors in individuals with dementia.
    Efjestad AS; Molden E; Oksengård AR
    J Am Geriatr Soc; 2013 Sep; 61(9):1624-5. PubMed ID: 24028363
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.